Mouse model of desmin-related cardiomyopathy

Circulation

Volumn 103, Issue 19, 2001, Pages 2402-2407

  Wang, Xuejun ^a   Osinska, Hanna ^a   Dorn II, Gerald W ^b   Nieman, Michelle ^b   Lorenz, John N ^b   Gerdes, A Martin ^c   Witt, Sandra ^a   Kimball, Thomas ^a   Gulick, James ^a   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c SANFORD RESEARCH   (United States)

Author keywords

Cardiomyopathy; Heart diseases; Molecular biology; Pathology; Physiology

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DESMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GENE MUTATION; MOUSE; MUSCLE FIBRIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYSTOLE; TRANSGENIC MOUSE;

EID: 14344283370     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.19.2402     Document Type: Article

References (21)

1. Milner DJ, Weitzer G, Tran D, et al. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol. 1996; 134:1255-1270.
2. Lockard VG, Bloom S. Trans-cellular desmin-lamin B intermediate filament network in cardiac myocytes. J Mol Cell Cardiol. 1993;25: 303-309.
3. Bloom S, Lockard VG, Bloom M. Intermediate filament-mediated stretch-induced changes in chromatin: a hypothesis for growth initiation in cardiac myocytes. J Mol Cell Cardiol. 1996;28:2123-2127.
4. Wang X, Li F, Campbell SE, et al. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs, II: cytoskeletal remodeling. J Mol Cell Cardiol. 1999;31:319-331.
5. Collins JF, Pawloski-Dahm C, Davis MG, et al. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol. 1996;28:1435-1443.
6. Heling A, Zimmermann R, Kostin S, et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res. 2000;86:846-853.
7. Goldfarb LG, Park KY, Cervenakova L, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet. 1998;19:402-403.
8. Munoz-Marmol AM, Strasser G, Isamat M, et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA. 1998;95:11312-11317.
9. Sjoberg G, Saavedra-Matiz CA, Rosen DR, et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet. 1999;8:2191-2198.
10. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 1999;100:461-464.
11. Abraham SC, DeNofrio D, Loh E, et al. Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy. Hum Pathol. 1998;29:876-882.
12. Dalakas MC, Park KY, Semino-Mora C, et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med. 2000:342:770-780.
13. Thomell L, Carlsson L, Li Z, et al. Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol. 1997;29:2107-2124.
14. Milner DJ, Taffet GE, Wang X, et al. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol. 1999;31:2063-2076.
15. Gulick J, Hewett TE, Klevitsky R, et al. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997; 80:655-664.
16. Sanbe A, Fewell JG, Gulick J, et al. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem. 1999;274:21085-21094.
17. Gerdes AM. A reliable, efficient, and comprehensive approach to assess myocyte remodeling in cardiac hypertrophy and failure. J Card Fail. 1997;3:63-68.
18. Jones WK, Grupp IL, Doetschman T, et al. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 1996;98:1906-1917.
19. Arbustini E, Morbini P, Grasso M, et al. Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol. 1998;31: 645-653.
20. Ip W. Modulation of desmin intermediate filament assembly by a monoclonal antibody. J Cell Biol. 1988;106:735-745.
21. Chu G, Dorn GW, Luo W, et al. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ Res. 1997;81:485-492.